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660Objective: Stroke remains a significant contributor to morbidity and mortality after cardiac surgery. Cardiopul-
monary bypass is known to induce a significant inflammatory response, which could adversely influence out-
comes. We hypothesized that cardiopulmonary bypass, through an enhanced systemic inflammatory response,
might affect outcomes after focal cerebral ischemia.
Methods:Wistar rats (275–300 g) were anesthetized, surgically prepared for cardiopulmonary bypass and right
middle cerebral artery occlusion, and randomly allocated to 2 groups: focal cerebral ischemia alone (n ¼ 9) and
focal cerebral ischemia combined with normothermic cardiopulmonary bypass (n ¼ 8). Serum cytokines (tumor
necrosis factor a and interleukins 1b, 6, and 10) were measured at baseline, at end of bypass, and at 2, 6, and 24
hours after bypass. On postoperative day 3, animals underwent neurologic testing, after which the brains were
prepared for assessment of cerebral infarct volume. Data were compared between groups by Mann–Whitney
U test.
Results:Compared with the ischemia-alone group, the ischemia plus bypass group had significantly higher levels
of circulating tumor necrosis factor a and interleukins 1b and 10 at the end of bypass and 2 hours after bypass. In
addition, the ischemia plus bypass animals had larger total cerebral infarct volumes (286  125 mm3) than did
those with ischemia alone (144  85 mm3, P ¼ .0124).
Conclusions: Cardiopulmonary bypass increased cerebral infarct size after focal cerebral ischemia in rats. This
worsening of outcome may in part be related to an augmented inflammatory response that accompanies cardio-
pulmonary bypass. (J Thorac Cardiovasc Surg 2010;140:660-6)Supplemental material is available online.Cardiac surgery is known to be associated with variable de-
grees of neurologic injury, ranging from relatively minor
neurocognitive deficits to more severe cerebral infarction.1,2
Although the mechanisms of perioperative stroke are not
fully understood, they most likely involve obstruction (by
thrombus or embolus) of a cerebral vessel or prolonged
cerebral hypoperfusion (particularly in a watershed area of
the brain).3 As a consequence, stroke is represented by
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The Journal of Thoracic and Cardiovascular Surga near-ischemic region (penumbral area) that is potentially
salvageable.4 In this penumbral region, inflammatory cells
infiltrate during the earliest hours after reperfusion. Experi-
mental and clinical data have shown that an influx of these
cells leads to a local inflammatory response that can exacer-
bate brain injury.5
The systemic inflammatory response that occurs during
cardiac surgery, and in particular cardiopulmonary bypass
(CPB), includes complement activation, endotoxemia, and
the release of cytokines.6 Accordingly, many studies have
demonstrated that CPB induces cytokine production, al-
though the mechanisms for this production are complex.7
Surgical trauma, blood contact with nonendothelialized sur-
faces of the CPB apparatus, and reperfusion injury (to the
gut, lungs, heart, and even the brain) are considered potential
causes of cytokine production.8 Systemic inflammation may
have effects on several organ systems. In experimental set-
tings, inflammation is well known to contribute to cerebral
ischemic injury. Clinical stroke studies have also shown a re-
lationship between elevated cytokines and adverse out-
comes, suggesting a pivotal role of inflammation in stroke
outcome.9
Because CPB has a demonstrable inflammatory response
and there is a known risk of stroke during cardiac surgery,
we proposed to determine whether CPB influences outcomeery c September 2010
Abbreviations and Acronyms
IL ¼ interleukin
CPB ¼ cardiopulmonary bypass
MCAO ¼ middle cerebral artery occlusion
TNF ¼ tumor necrosis factor
Homi et al Evolving Technology/Basic Scienceafter focal cerebral ischemia. Specifically, we wished to dis-
cover whether the systemic inflammatory response triggered
by CPB adversely affects cerebral infarct volume and func-
tional outcome.E
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The Duke University Institutional animal care and use committee ap-
proved this study, and all procedures met the National Institute of Health
guidelines for animal care (‘‘Guide for the Care and Use of Laboratory
Animals,’’ www.nap.edu/catalog/5140.html).
Surgical Procedures
MaleWistar rats (12–14weeks old, bodyweight 275–300 g; Harlan Lab-
oratories, Inc, Indianapolis, Ind) were kept fasting for 12 hours overnight
but allowed free access to water before experiments. The animals were anes-
thetized in a chamber with 3% isoflurane in 50% oxygen, with the balance
nitrogen. The trachea was intubated (14-gauge catheter), the lungs were me-
chanically ventilated (Harvard Rodent Ventilator; Harvard Apparatus, Bos-
ton, Mass), and the isoflurane concentration was reduced (1.5%–2.0%).
Ventilatory parameters were adjusted to produce an arterial PCO2 of 36 to
42 mm Hg. Pericranial temperature (measured with a needle thermistor in-
serted in the left temporal muscle adjacent to the skull) was servo-controlled
(YSI 400 series thermistor and 73 ATA Indicating Controller; YSI Incorpo-
rated Life Sciences, Yellow Springs, Ohio) with both forced-air and surface
heating systems to a defined target temperature of 37.5C. Rectal tempera-
ture (core temperature) was also monitored.
The animals were then prepared for CPBwith the right superficial caudal
epigastric artery cannulated (PE-10 Intramedic polyethylene tubing; BDDi-
agnostics, Sparks, Md) for continuous monitoring of mean arterial pressure
and for arterial blood gas analysis (IL-1306 blood gas analyzer; Instrumen-
tation Laboratory, Bedford, Mass). The ventral tail artery was cannulated,
and 100 units of heparin administered (20-gauge 1.16 inch intravenous cath-
eter Insyte-WTM; BD Medical, Medical Surgical Systems, Infusion Ther-
apy, Sandy, Utah). This catheter was used for the arterial inflow to the
CPB circuit. With a PE-50 catheter (Intramedic polyethylene tubing), the
tail vein was cannulated for drug infusion during CPB. A midline anterior
cervical incision was then performed, and the right external jugular vein
was identified and isolated for later cannulation. The right carotid artery
was then surgically prepared for middle cerebral artery occlusion
(MCAO). With blunt dissection, the right external and internal carotid ar-
teries were identified and isolated with 5-0 silk sutures. The external carotid
artery was ligated remote from its origin, and the proximal end was tempo-
rarily occluded with a microsurgical aneurysm clip, allowing subsequent in-
traluminal filament insertion (4-0 nylon monofilament, tip heat-blunted and
coated with silicone). The jugular vein was incised, and a multiorifice dual-
stage venous cannula (modified from a 4.5F Desilets-Hoffman Pediatric In-
troducer; Cook Incorporated, Bloomington, Ind) was inserted and advanced
into the right side of the heart to serve as the venous return cannula. All an-
imals received 100 IU heparin intravenously after placement of the first
cannula.
The CPB circuit was a custom-made apparatus consisting of a reservoir
that collected the venous blood from the external jugular vein and wasThe Journal of Thoracic and Calocated 12 cm below the heart to create a gravity drainage gradient. The ve-
nous blood from the reservoir flowed to a peristaltic pump (Masterflex;
Cole-Parmer Instrument Company, Vernon Hills, Ill) through silicone tub-
ing (1.6 mm internal diameter, Tycon; Cole-Parmer) and was pumped
through a small custom-made membrane oxygenator. The oxygenator con-
sisted of 2 polymethylmethacrylate (Plexiglas; Altuglas International, Ar-
kema Inc, Philadelphia, Pa) shells that allowed the insertion of 3 layers of
diffusion membrane (558 cm2, total gas-exchanging surface area) glued to-
gether with epoxy in a crosswise fashion. This device was manufactured to
permit blood gas exchange but also served as a heat exchanger by being at-
tached to a system in which a continuous flow of warm water was used to
maintain target blood temperature. The CPB flow was continuously moni-
tored with a flow probe located within the circuit (2N806 flow probe and
T208 volume flowmeter; Transonic Systems Inc, Ithaca, NY). The CPB cir-
cuit was primed with 10 mLwhole blood obtained from a single heparinized
(100 IU heparin intravenously per animal) and anesthetized donor rat
through a cannula inserted in a right external jugular vein.
Experimental Design
After surgical preparation, the animals were allowed to stabilize for 15
minutes and then were randomly allocated to 1 of 2 groups: MCAO-alone
group (n ¼ 9) or MCAO plus CPB group (n ¼ 8). MCAO was performed
by insertion of the 4-0 monofilament through the external carotid artery
stump. The filament was advanced until resistance was felt as the tip oc-
cluded the circle of Willis at the origin of the middle cerebral artery. The
animals in the MCAO-alone group had the focal ischemia maintained for
90 minutes, after which the brain was reperfused as a consequence of fila-
ment withdrawal. In the MCAO plus CPB group, the ventilation was
stopped after MCAO was established and normothermic (37.5C) CPB
was initiated. Isoflurane anesthesia (1.2% inspired) was maintained during
CPB in all groups, and atracurium (0.3 mg/kg intravenously, repeated every
25 minutes) was administered. CPB (flow rate 160–190 mL $ kg1 $ min1)
was carried out for 75 minutes. The MCAO filament was removed as in the
MCAO-alone animals after 90 minutes of focal cerebral ischemia. The an-
imals remained anesthetized and ventilated for an additional 120minutes af-
ter CPB ended (or equivalent time for MCAO-alone animals). At the end of
the experiment, the venous return cannula was changed to a PE-50 catheter
that was implanted to allow the collection of serial blood samples after an-
imal recovery (6 and 24 hours after CPB). All other catheters were removed
2 hours after CPB. The wounds were infiltrated with 1% lidocaine and
closedwith silk sutures. The heparin was allowed to dissipate spontaneously
without protamine administration. The rats were allowed to recover in
a chamber (inspired oxygen fraction 0.5) with a controlled environmental
temperature (25C) for 24 hours before being transferred to their regular
cages.
Neurologic Evaluation
Seventy-two hours after surgery, the rats underwent functional neuro-
logic evaluation by an observer blinded to group assignment.10 This func-
tional testing (neuroscore, in which 18 points represents normal behavior)
assessed spontaneous activity as follows: no movement (0 points) to normal
behavior (3 points); motor symmetry in all limbs as no movement at the left
side (0 points) to normal behavior (3 points), motor symmetry in the fore-
limbs as no movement (0 points) to normal motor symmetry (3 points),
climbing as falling trying to climb (1 point) to normal climbing (3 points),
body proprioception as no response at left side (1 point) to symmetric re-
sponse (3 points), and response to vibrissae touch as no response on the
left side (1 point) to symmetric response (3 points).
Serum Cytokine Analyses
Venous blood samples were collected from the right external jugular
vein just before MCAO (baseline), at the end of CPB (or equivalent time
for MCAO animals), and then at 2, 6, and 24 hours after CPB (or equivalentrdiovascular Surgery c Volume 140, Number 3 661
TABLE 1. Physiologic values
Parameter
MCAO
(n ¼ 9)
MCAO plus
CPB (n ¼ 8)
P
value
Body weight (g) 283  10 295  10 .0231
Mean arterial pressure (mm Hg)
Baseline 77  4 75  4 .1625
30 min 74  6 75  6 .9180
90 min 74  4 73  4 .7675
210 min 72  7 72  8 .9970
Pericranial temperature (C)
Baseline 37.4  0.1 37.4  0.1 .9347
30 min 37.2  0.1 37.1  0.2 .0841
90 min 37.4  0.1 37.4  0.1 .3124
210 min 37.4  0.1 37.4  0.1 .0962
Hemoglobin (g/dL)
Baseline 16  1 17  1 .4615
30 min 15  1 14  2 .0461
90 min 15  1 13  1 .0021
210 min 15  1 13  2 .0031
Hematocrit (%)
Baseline 39%  2% 39%  2% .7366
30 min 36%  2% 33%  2% .0215
90 min 37%  2% 31%  3% .0004
210 min 36%  1% 31%  3% .0009
Glucose (mg/dL)
Baseline 88  11 75  7 .0077
90 min 98  10 95  10 .5845
210 min 105  20 116  13 .1932
CPB flow
(mL/[kg $ min])
30 min — 179  11
90 min — 178  8
Values are mean  SD. The 30- and 90-minute time points were during cardiopulmo-
nary bypass, and the 210-minute time point was 120 minutes after cardiopulmonary
bypass (middle cerebral artery occlusion–alone group had measurements at corre-
sponding time points). MCAO, Middle cerebral artery occlusion, CPB, cardiopulmo-
nary bypass.
TABLE 2. Arterial blood gas values
Parameter
MCAO
(n ¼ 9)
MCAO plus
CPB (n ¼ 8)
P
value
Arterial pH
Baseline 7.39  0.02 7.39  0.03 .8633
30 min 7.40  0.01 7.37  0.06 .4273
90 min 7.39  0.02 7.38  0.03 .2440
210 min 7.38  0.04 7.39  0.03 .3060
Arterial PCO2 (mm Hg)
Baseline 40  3 39  4 .6719
30 min 37  4 40  6 .4145
90 min 37  3 42  2 .0491
210 min 40  5 39  4 .8594
Arterial PO2 (mm Hg)
Baseline 171  44 176  43 .8126
30 min 184  63 247  76 .3095
90 min 210  55 182  78 .4005
210 min 184  24 228  90 .1806
Bicarbonate (mEq/L)
Baseline 25  1 25  2 .7427
30 min 24  3 24  1 .8622
90 min 24  2 25  2 .0393
210 min 24  2 25  2 .3129
Base excess (mmol/L)
Baseline 0.5  1.1 0.3  1.7 .8237
30 min 0.3  1.8 0.6  1.4 .7638
90 min 0.4  1.2 0.6  0.8 .0611
210 min 0.2  0.8 0.7  1.4 .0867
Values are mean  SD. The 30- and 90-minute time points were during cardiopulmo-
nary bypass, and the 210-minute time point was 120 minutes after cardiopulmonary
bypass (middle cerebral artery occlusion–alone group had measurements at corre-
sponding time points). MCAO,Middle cerebral artery occlusion, CPB, cardiopulmo-
nary bypass.
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and the serumwas frozen and stored (80C) for later analysis. Serum tumor
necrosis factor (TNF) a and interleukins (ILs) 1b, 6, and 10 were analyzed
by multiplexed sandwich enzyme-linked immunosorbent assay microtiter
plate according to manufacturer instructions (Endogen Search Light; Endo-
gen, Inc, Woburn, Mass). Results were expressed as picograms per millime-
ter, and sensitivities for detection were 3.1 pg/mL for TNFa, 3.1 pg/mL for
IL1b, 6.3 pg/mL for IL6, and 0.4 pg/mL for IL10.
Cerebral Infarct Volume Assessment
After neurologic evaluation, the animals were deeply anesthetized with
5% isoflurane and decapitated. Each brain was immediately removed, im-
mersed in methylbutane, and frozen (35C), after which it was sectioned
and the infarct volume was measured according to a previously described
method.11 Briefly, coronal sections were made (20 mm thickness), and 4 se-
quential slices were collected and slide mounted. The next 33 sections were
discarded, and then a new 4-slice cycle was begun. The process began with
the most rostral slice in which the cerebral infarct was evident and continued
throughout the extent of the infarct. The sections were stained with hema-
toxylin and eosin. Then the brain sections were digitized (12893 960 ma-
trix of 210-mm2 pixel units) with an image analysis system (M2 Turnkey
System; Imaging Research Inc, St Catharines, Ontario, Canada). The infarct662 The Journal of Thoracic and Cardiovascular Surgboundaries were separately delineated for the cortical and subcortical struc-
tures by an observer (H.M.H.) blinded to group assignment. Infarct volumes
were computed as running sums of infarct area multiplied by the known in-
terval (eg, 660 mm) between sections over the extent of the infarct expressed
as an orthogonal projection.
Statistical Analysis
Normally distributed physiologic variables and arterial blood gas data
were expressed as mean  SD, and differences between groups were com-
pared with the unpaired Student t test. For serum cytokine concentrations,
which were not normally distributed, the nonparametric Mann–Whitney
U test was applied as appropriate. In addition, cerebral infarct volumes
and neuroscores were compared between groups with the Mann–Whitney
U test. The nonparametric data were expressed as median with interquartile
range.
RESULTS
Physiologic values and arterial blood gas analyses are
shown in Tables 1 and 2. Few differences between groups
were present (mainly related to hemoglobin and hematocrit
concentrations at the end of CPB). The lower values in the
MCAO plus CPB animals are attributable to minor hemodi-
lution occurring during the procedure. Also, the animals that
underwent CPB had slightly lower baseline glucose serum
levels than did the MCAO-alone animals (Table 1).ery c September 2010
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FIGURE 1. Middle cerebral artery occlusion plus cardiopulmonary bypass (MCAOþCPB) group had significantly higher circulating levels of tumor necrosis
factor a (A, TNFa), interleukin 1b (B, IL1b), and interleukin 10 (D, IL10) at end of cardiopulmonary bypass (CPB) and at 2 hours after cardiopulmonary
bypass relative to middle cerebral artery occlusion–alone (MCAO) group. There were no differences in cytokine levels at other time points. For interleukin
6 (C, IL6), there were no differences at any time point. Values are median with interquartile range. Asterisk indicates P<.05 (between-group comparisons).
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SThe serum cytokine values were significantly different be-
tween groups. Relative to the MCAO-alone group, the
MCAO plus CPB group had increased cytokine levels
throughout the experiment. TNFa and IL1b had increased
serum concentrations at the end of CPB, with maximum
values 2 hours after CPB that rapidly decreased to normal
at 6 hours after CPB (Figure 1, A and B). IL10 showed a sim-The Journal of Thoracic and Cailar pattern but reached its maximum concentration at the
end of CPB and then decayed slowly to below a detectable
threshold at 24 hours after CPB (Figure 1, D). Although
the IL6 level was increased 2 hours after CPB in the
MCAO plus CPB group because of high levels in just
a few animals, there was no difference in median value rel-
ative to the MCAO-alone group (Figure 1, C).rdiovascular Surgery c Volume 140, Number 3 663
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FIGURE 2. For neurologic evaluation, standard neurologic testing (neuro-
score with 18 points corresponding to normal behavior) demonstrated
strong correlation between neuroscore and cerebral infarct size. Neuroscore
values were not significantly different between groups (median, 10 [inter-
quartile range, 7–13] for middle cerebral artery occlusion–alone [MCAO]
group vs median, 8 [interquartile range, 4–12] for middle cerebral artery oc-
clusion plus cardiopulmonary bypass [MCAOþCPB] group); however,
there was trend toward worsened functional neurologic outcome in middle
cerebral artery occlusion plus cardiopulmonary bypass group (P ¼ .1939).
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SAlthough there was a good correlation (Figure 2) between
cerebral infarct size and worsening results of neurologic
functional testing, the neuroscore values were not statisti-
cally different between groups (10 [interquartile range, 7–
13] in MCAO group vs 8 [interquartile range, 4–12] in
MCAO plus CPB group, P ¼ .1939). In addition, there
was a trend toward relationships between cytokine responses
and cerebral infarct volume, but these relationships were not
statistically significant. For example, the correlation be-
tween TNFa at the end of CPB and total cerebral infarct vol-
ume trended toward significance (R2 ¼ 0.21, P ¼ .07;
Figure E1).
Histologic analyses of brain infarct volumes (total and
cortical and subcortical components) are shown in Figure 3.
The MCAO plus CPB animals had larger total cerebral in-
farct volumes than did MCAO-alone animals (Figure 3,
A), primarily attributable to differences in cortical infarct
volume (Figure 3, B).0
MCAO MCAO+CPBC
FIGURE 3. In histologic analysis, middle cerebral artery occlusion plus
cardiopulmonary bypass (MCAOþCPB) group had larger cerebral infarct
volumes than did middle cerebral artery occlusion–alone (MCAO) group.
A, Total infarct volume (middle cerebral artery occlusion–alone group
144  85 mm3 vs middle cerebral artery occlusion plus cardiopulmonary
bypass group 286 125 mm3). B, Cortical infarct volume (middle cerebral
artery occlusion–alone group 89 63 mm3 vs middle cerebral artery occlu-
sion plus cardiopulmonary bypass group 195 81 mm3). C, Subcortical in-
farct volume (middle cerebral artery occlusion–alone group 55 28mm3 vs
middle cerebral artery occlusion plus cardiopulmonary bypass group 90 
45 mm3). Values are mean  SD.DISCUSSION
In this study of CPB superimposed on cerebral ischemia,
animals that were exposed to CPB had larger cerebral infarct
volumes than did animals that were not exposed to CPB.
This may in part have been the result of the enhanced
CPB-induced inflammatory response that was demonstrated
in these animals.
Wide-ranging central nervous system injuries have been
reported after cardiac surgery. Focal or global brain ischemia
associated with CPB is frequently implicated in these central
nervous system injuries.2 Focal neurologic deficits follow664 The Journal of Thoracic and Cardiovascular Surgery c September 2010
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atheromatous or other large particulate debris) or thrombosis
in cerebral arterial vessels.3 Moreover, microemboli (varia-
bly composed of air, fat, thrombus, and atheromatous frag-
ments) in distal cerebral arteries have been related to
stroke as well as to neurocognitive dysfunction.12 In addi-
tion to embolization, inflammation, either cerebral or sys-
temic, has also been implicated in CPB-related cerebral
injury.2
The inflammatory response occurring after cardiac sur-
gery is initiated by several factors, including blood contact
with artificial surfaces in the CPB circuit, surgical trauma,
ischemia–reperfusion injury, and endotoxemia. Although
measurement of cytokine levels has been widely used to as-
sess inflammation after CPB, the relationship between the
magnitude of these markers and organ dysfunction has not
been well established. Cytokines modulate local inflamma-
tory responses but also have systemic effects.13 The sources
of cytokine production after CPB are the heart, lungs, gut,
and brain.14 In each of these organs, increased local concen-
trations of cytokines have been associated with heart failure,
prolonged mechanical ventilatory support, endotoxemia,
and brain injury.9,15 Products of increased local cytokine
production may migrate into the systemic circulation and
could further trigger a systemic inflammatory response.
In addition to the risk of focal cerebral ischemia, patients
undergoing cardiac surgery also face the superimposition of
variable degrees of inflammation in the perioperative period.
In a recent clinical study, increases in cytokines and soluble
TNF receptor 1 were associated with brain injury in patients
who underwent CPB.9 In that study, several serum inflam-
matory markers were measured in patients who had postop-
erative cerebral damage and compared with those in patients
without stroke. Serum levels of TNFa and IL10 were higher
in the stroke group at 12 and 24 hours after CPB. Although
IL 6 levels in the stroke group were higher than those in the
group without stroke, these values were not statistically dif-
ferent. The study’s authors suggested the possibility that the
increased cytokines levels in patients with stroke may be as-
sociated with augmentation of inflammatory responses in the
injured brain during or after CPB.9
The mechanism by which enhanced inflammation may
have an impact is likely related to the susceptibility of the
penumbral area to damage by inflammatory cells.16 After fo-
cal brain ischemia, there is an influx of inflammatory cells to
the penumbral area.17 These cells migrate to this region and
infiltrate the brain parenchyma after mediation by adhesion
molecules that are, at least in part, affected by proinflamma-
tory cytokines.18 It is logical to speculate that CPB-induced
cytokine production might amplify this initial response.
In our study, proinflammatory cytokines TNFa and IL1b
were increased during CPB. They continued to increase after
cessation of CPB and then began to decrease toward base-
line values. The IL10 levels, representing a counteractiveThe Journal of Thoracic and Caanti-inflammatory process, were in accordance with previ-
ous results that showed a phased increase and then a slow
decrement temporally related to CPB.13 Although IL6
peaked at 2 hours after CPB in the MCAO plus CPB group,
we were unable to demonstrate any differences at the time
points studied. IL6 is considered a potent proinflammatory
cytokine but has a short half-life in plasma.13 Our scheduled
sampling time points for cytokine screening may have pre-
cluded the detection of transient IL6 increases.
There were some limitations of this study. Minor physio-
logic differences were present between the groups related to
hematocrit and glucose. Mild hemodilution occurred during
CPB, in the final stages of the MCAO, and early during re-
perfusion. This may have served to mitigate some of the in-
jury that was seen, because mild to moderate levels of
hemodilution have previously been associated with neuro-
protection after brain ischemia.19 Experimental and clinical
studies have described an optimal hematocrit of approxi-
mately 30% as the most favorable level for protection
from focal cerebral ischemia.20,21 Our study showed hemat-
ocrit values near this optimal set point after CPB. With re-
spect to glucose, baseline values were marginally higher
(only 13 mg/dL) in the MCAO-alone group. In clinical
and experimental settings, higher glucose levels have been
extensively associated with larger brain infarcts and poor
neurologic outcome.22 If anything, however, this increase
in glucose in the MCAO-alone group would have served
to decrease differences between groups.
A second limitation of this study is related to the need for
the addition of blood to prime the CPB system. The CPB
system was blood primed in an attempt to maintain similar
hemoglobin levels between groups, thus avoiding confound-
ing factors that could be caused by excessive hemodilution.
Transfusion has been a variable risk factor for adverse out-
come after CPB; however, confounding this risk is the age
of the products transfused.23 Because we used fresh blood
donors, it is unlikely that this was a significant factor in
our results. Other CPB experiments performed in our labo-
ratory make it unlikely that the blood prime, rather than
CPB itself, had an effect on the enhanced inflammation in
the CPB group. Animals that have undergone bloodless
priming of the circuit have demonstrated a similar inflamma-
tory response pattern (unpublished data). Another limitation
relates to the stroke model itself. MCAO was produced in
these animals by filament insertion through the carotid ar-
tery. This is different from the mechanism of stroke occur-
ring during clinical CPB, in which it is more likely that
embolic material consists of either thrombus or atheroscle-
rotic material. As a result, the cerebral ischemia produced
in our study was transient, whereas in the clinical setting it
is more likely to be permanent.
Although these experiments were performed with strictly
normothermic CPB, in clinical situations, it is more likely
for tepid temperatures to be used. As a result, applicationrdiovascular Surgery c Volume 140, Number 3 665
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tions may not be appropriate. That said, the trend toward us-
ing less significant degrees of hypothermia makes this
limitation arguably minor.
The relatively short postoperative follow-up may repre-
sent a final potential limitation. There are 2 reasons we chose
postoperative day 3 to analyze the cerebral infarct size in our
protocol. First, the systemic inflammation, as measured by
serum cytokines, was undetectable 24 hours after surgery.
We can assume that the systemic component of the inflam-
mation will not have any effect in the brain 3 days after sur-
gery. Also, in other MCAO studies in rats the infarct
volume, although changing significantly between 6 and 72
hours, had little change after that.17 Moreover, studies
have shown that neutrophil infiltration in the ischemic hemi-
sphere starts as early as 1 hour after reperfusion, increasing
significantly by 6 to 12 hours.24 Others have demonstrated
that the number of neutrophils peaks between 24 and 72
hours and then decreases sharply.25 After 3 days, the ische-
mic tissue follows progressive stages of matrix organization
for approximately 2 weeks, when the necrotic tissue is re-
moved and glial scar is formed.24
Normothermic CPB appears to affect neurologic outcome
adversely after focal cerebral ischemia induced by reversible
MCAO.We suggest that these results are at least partially at-
tributable to the systemic inflammatory response triggered
by CPB. The association between the systemic inflammatory
response after CPB and deleterious neurologic outcome in-
dicates that this response may provide a target for neuropro-
tective strategies.References
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FIGURE E1. Correlation between inflammatory cytokine tumor necrosis
factor a (TNFa) levels at end of cardiopulmonary bypass (CPB) with total
cerebral infarct volume on postoperative day 3. MCAO, Middle cerebral
artery occlusion–alone; MCAOþCPB, middle cerebral artery occlusion
plus cardiopulmonary bypass.
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